qPULA Trading Management’s bluebird bio BLUE Stock Holding History

qPULA Trading Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-717	Closed	-$91K	–	7
2022 Q3	$91K	Buy	+717	New	+$81.1K	0.8%	36

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

qPULA Trading Management's BLUE Position: Q4 2022 in Review

qPULA Trading Management sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 717 shares — an estimated $91K sold.

qPULA Trading Management first reported a position in BLUE in Q3 2022 and held it in 1 quarter. The position peaked at $91K in Q3 2022. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

qPULA Trading Management reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
qPULA Trading Management sold 717 bluebird bio shares in Q4 2022, an estimated $91K.
qPULA Trading Management first reported a position in bluebird bio in Q3 2022 and held it in 1 quarter.
qPULA Trading Management's bluebird bio position peaked at $91K in Q3 2022.
184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on qPULA Trading Management's 13F filing for Q4 2022, filed 13 Feb 2023.